|
NOTES PAYABLE - Notes Payable to Related Parties (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
|
12 Months Ended |
0 Months Ended |
|
|
|
|
|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Jul. 02, 2014
|
Jun. 24, 2013
|
Jun. 23, 2013
|
Feb. 28, 2011
|
Jan. 01, 2009
|
Nov. 28, 2012
|
Dec. 31, 2012
|
Jan. 08, 2014
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Fair value of promissory note |
$ 0 |
$ 12,406 |
|
$ 11,775 |
|
|
|
|
|
|
| Cumulative deferred interest payments |
0 |
53 |
|
|
|
|
|
|
|
|
| Converted instrument, options issued (in shares) |
|
1,000,000 |
|
|
|
|
|
|
|
|
| Exercise price of warrants |
$ 12.00 |
|
|
|
|
|
|
|
|
|
| Number of securities called by warrants (in shares) |
|
|
|
|
|
14,000,000 |
|
|
|
|
| Former SAE Common Stockholders | CLCH |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Maximum credit line |
|
|
|
|
|
|
3,000 |
|
|
|
| Annual interest rate |
|
|
|
|
|
|
8.50% |
|
|
|
| Notes Payable | 2012 Credit Agreement |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Stated interest rate |
|
|
|
|
|
|
|
13.50% |
|
|
| Notes Payable | Former SAE Common Stockholders |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Debt, principal amount |
|
|
|
17,500 |
|
|
|
|
|
|
| Notes Payable | Former SAE Common Stockholders | 2012 Credit Agreement |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Cumulative deferred interest payments |
|
|
2,007 |
|
|
|
|
|
|
|
| Notes Payable | Former SAE Common Stockholders | CLCH |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Debt, principal amount |
|
|
|
17,500 |
|
|
|
|
|
|
| Stated interest rate |
|
|
|
10.00% |
|
|
|
|
|
|
| Fair value of promissory note |
|
|
|
11,775 |
|
|
|
|
|
|
| Discount rate |
|
|
|
17.60% |
|
|
|
|
|
|
| Maximum credit line |
|
|
|
|
|
|
3,000 |
|
|
|
| Annual interest rate |
|
|
|
|
|
|
8.50% |
|
|
|
| Outstanding balance |
|
|
|
|
|
|
|
|
53 |
|
| Notes Payable | Directors |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Converted instrument, options issued (in shares) |
|
1,000,000 |
|
|
|
|
|
|
|
|
| Exercise price of warrants |
|
$ 12.00 |
|
|
|
|
|
|
|
|
| Number of securities called by warrants (in shares) |
|
|
|
|
|
|
|
|
|
100,000 |
| Notes Payable | Directors | Warrant exchange |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrants authorized (in shares) |
|
|
|
|
|
|
|
|
|
1,000,000 |
| Notes Payable | Directors | Eric S. Rosenfeld |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Convertible promissory notes |
|
|
|
|
300 |
|
|
|
|
|
| Notes Payable | Directors | David D. Sgro |
|
|
|
|
|
|
|
|
|
|
| Debt Instrument [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Convertible promissory notes |
|
|
|
|
$ 200 |
|
|
|
|
|